Rigel Pharmaceuticals
RIGL
RIGL
108 hedge funds and large institutions have $278M invested in Rigel Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 110 → 108 (-2)
7% less capital invested
Capital invested by funds: $299M → $278M (-$21.2M)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
108
Holding in Top 10
2
Calls
$401K
Puts
$105K
Top Buyers
| 1 | +$2.47M | |
| 2 | +$2.31M | |
| 3 | +$2.08M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.07M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
+$1.02M |
Top Sellers
| 1 | -$5.59M | |
| 2 | -$4.2M | |
| 3 | -$1.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.09M |
| 5 |
BlackRock
New York
|
-$950K |